Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Raised to $188 at Truist Securities Following Earnings

May 4, 2021 2:01 PM
Truist Securities analyst Kaila Krum raised the price target on Zimmer Biomet (NYSE: ZBH) to $188.00 (from $174.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles